A detailed history of Ubs Group Ag transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 8,407 shares of IGMS stock, worth $145,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,407
Previous 13,331 36.94%
Holding current value
$145,104
Previous $128,000 55.47%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.51 - $11.47 $32,055 - $56,478
-4,924 Reduced 36.94%
8,407 $57,000
Q1 2024

May 13, 2024

BUY
$8.68 - $17.36 $1,137 - $2,274
131 Added 0.99%
13,331 $128,000
Q4 2023

Feb 09, 2024

BUY
$3.94 - $8.79 $24,424 - $54,489
6,199 Added 88.54%
13,200 $109,000
Q3 2023

Nov 09, 2023

SELL
$6.66 - $10.64 $6,360 - $10,161
-955 Reduced 12.0%
7,001 $58,000
Q2 2023

Aug 11, 2023

BUY
$8.86 - $14.0 $27,891 - $44,072
3,148 Added 65.47%
7,956 $73,000
Q1 2023

May 12, 2023

BUY
$13.74 - $25.76 $11,679 - $21,896
850 Added 21.48%
4,808 $66,000
Q4 2022

Feb 08, 2023

BUY
$15.45 - $26.02 $57,443 - $96,742
3,718 Added 1549.17%
3,958 $67,000
Q3 2022

Nov 10, 2022

SELL
$15.42 - $27.01 $9,190 - $16,097
-596 Reduced 71.29%
240 $5,000
Q2 2022

Aug 10, 2022

SELL
$13.27 - $25.5 $3,410 - $6,553
-257 Reduced 23.51%
836 $15,000
Q1 2022

May 16, 2022

SELL
$13.42 - $29.73 $691,881 - $1.53 Million
-51,556 Reduced 97.92%
1,093 $29,000
Q4 2021

Feb 14, 2022

BUY
$27.59 - $66.39 $494,081 - $1.19 Million
17,908 Added 51.55%
52,649 $1.55 Million
Q3 2021

Nov 15, 2021

BUY
$65.76 - $90.65 $2.02 Million - $2.79 Million
30,739 Added 768.09%
34,741 $2.28 Million
Q2 2021

Aug 13, 2021

SELL
$57.98 - $96.6 $710,776 - $1.18 Million
-12,259 Reduced 75.39%
4,002 $333,000
Q1 2021

May 12, 2021

BUY
$71.56 - $121.23 $1.15 Million - $1.95 Million
16,087 Added 9245.4%
16,261 $1.25 Million
Q4 2020

Feb 11, 2021

SELL
$47.41 - $115.03 $255,587 - $620,126
-5,391 Reduced 96.87%
174 $15,000
Q3 2020

Nov 12, 2020

BUY
$43.0 - $84.01 $224,890 - $439,372
5,230 Added 1561.19%
5,565 $411,000
Q2 2020

Jul 31, 2020

SELL
$51.3 - $75.21 $136,817 - $200,585
-2,667 Reduced 88.84%
335 $24,000
Q1 2020

May 01, 2020

SELL
$31.51 - $73.75 $130,987 - $306,578
-4,157 Reduced 58.07%
3,002 $169,000
Q4 2019

Feb 14, 2020

BUY
$17.25 - $49.51 $123,492 - $354,442
7,159 New
7,159 $273,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.